Navigation Links
Overweight toddlers and those not in day care at risk for iron deficiency
Date:9/3/2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...he National Institute of Diabetes and Digestive an...stitutes of Health (NIH), announces awards to eigh...ve studies of urologic chronic pelvic pain disorde...ostate. The total research investment for the five...on. , "The launch of this novel research effort ...
(Date:9/5/2008)...IDLOTHIAN, Va., Sept. 5 /PRNewswire/ -- On Saturda... featured on the Oxygen Network show Today,s,Famil...s highlighted as a,leading medical device company ...th effective nebulizers and compressors that deliv...r vision is to improve the lives of those affected...
(Date:9/5/2008)...TLANTA, Sept. 5 /PRNewswire/ -- EthicAd, a nonprof... through consumer education, announces,the launch ...public better,understand direct-to-consumer (DTC) ... "Be Smart About Prescription Drug Advertising," i...nd Research and was,developed by the FDA in partne...
(Date:9/5/2008)... finds risk is greatest for those overweight or ob...hDay News) -- Almost half of all American adults w...and their odds increase if they are obese in middl...having the painful condition increased as his or h...iversity of North Carolina at Chapel Hill study. P...
Breaking Medicine News(10 mins):Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 2Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 3Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Prescription Drug Advertising Subject of New FDA Web Site for Consumers 2Health News:Almost Half of Adults Will Develop Knee Osteoarthritis by 85 2
...s been the cause of many infant deaths, which has ...back. In a bid to investigate the// latent tendenc...iscovered that infants born with an anomaly in thr...he risk of SIDS. The study has undoubtedly made ...
...nsurance, leading hospital chain Max Healthcare We...n offering benefits of a family// physician, speci... annual package. Simultaneously, the hospital cha...of facilities in the national capital region to ni...
...as decreased in the last ten years, according to n... to changes in sexual behavior// . The study comp...1999-2004 and found that the rate of genital herpe... to 17 percent. 'The most exciting finding is tha...
...miscarriage at an emergency room in Calgary, have ...gion to review emergency care.// The health qualit...will begin the process next month. Rick Lundy had... beds in the emergency room at he Peter Lougheed c...
Other Medicine News:Health News:Max Healthcare Launches Outpatient Health Plans 2
(Date:9/4/2008)...ctivity and favorable safety ...Newswire-FirstCall/ -- Idenix,Pharmaceuticals, Inc...gaged,in the discovery and development of drugs fo...s diseases, today announced that it has completed ...n-nucleoside reverse,transcriptase inhibitor (NNRT...
(Date:9/3/2008)...en Studied. Wrong,Conclusions Reached., NIXA, Mo.... Disease,Control and Prevention (CDC) study releas...accine and autism. The National Autism Association...growing public concern over a,vaccine-autism conne...gn,and methodology., For years, parents have clai...
(Date:9/3/2008)...se Awareness Month, CHARLOTTESVILLE, Va., Sept. 3...clinical-stage drug-development company commercial... needs, announced today that it has begun,to enrol...ead drug,candidate trans sodium crocetinate (TSC)....trials.gov Website, is investigating TSC as a trea...
(Date:9/3/2008)...ns with FDA, PRINCETON, N.J., Sept. 3 /PRNewswire...t it successfully completed two key clinical trial...ive low-dose, once-weekly,contraceptive patch, wh...code AG-200-15. The Phase 2b safety and efficacy s...ation suppression, cycle control and safety. The,p...
Breaking Medicine Technology:Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4CDC Misses Target With Flawed MMR/Autism Study 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Chemistry turns killer gas into potential cure 805 1Chemistry turns killer gas into potential cure 805 2Testosterone turns male juncos into blustery hunks and bad dads 803 1Testosterone turns male juncos into blustery hunks and bad dads 803 2Testosterone turns male juncos into blustery hunks and bad dads 803 3Neuromed Concludes a Special Protocol Assessment 28SPA 29 with FDA for a Pivotal Phase 3 Study on NMED 1077 3669 1Neuromed Concludes a Special Protocol Assessment 28SPA 29 with FDA for a Pivotal Phase 3 Study on NMED 1077 3669 2Neuromed Concludes a Special Protocol Assessment 28SPA 29 with FDA for a Pivotal Phase 3 Study on NMED 1077 3669 3Holiday Entertaining with Style and Good Health 3667 1Holiday Entertaining with Style and Good Health 3667 2
Transcranial vascular DWL doppler.
Transcranial vascular DWL doppler.
Transcranil vascular DWL doppler.
...m Viasys Neurocare is a full-featured physiologic ...table size. It contains many of the features of ou...t an economical price. , ,The smaller size of ...ironment, the physician's office, a mobile service...
Medicine Products: